Molecular genetics and in vitro sensitivity of a new human cell line, KKP, from a gastric adenocarcinoma

Cancer Genetics and Cytogenetics

Volumn 105, Issue 1, 1998, Pages 43-49

  Zoli, W ^a   Ricotti, L ^a,b,c   Lenzi, L ^b   Roncuzzi, L ^a,b,c   Zini, N ^e   Amadori, D ^a   Gruppioni, R ^d   Sensi, A ^d   Gasperi Campani, A ^b  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; ANTINEOPLASTIC AGENT; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CELL DNA; CISPLATIN; CYCLIN E; DOXORUBICIN; ETOPOSIDE; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR ANTIGEN;

ADULT; ANEUPLOIDY; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CHROMOSOME 12; CHROMOSOME 13; CHROMOSOME 14; CHROMOSOME 18; CHROMOSOME 7; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DOUBLE MINUTE CHROMOSOME; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; TETRASOMY; TRISOMY;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032146584     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00010-7     Document Type: Article

References (29)

1. Fuchs C.S., Mayer R.J. Gastric carcinoma. New Engl J Med. 333:1995;32-41.
2. Alexander HR, Kelsen PD, Tepper JE (1993): Cancer of the stomach. In Cancer: Principles and Practice of Oncology. VT De Vita, S Hellman, SA Rosenberg, eds. Lippincott, Philadelphia, pp. 818-848.
3. Kelsen D., Atiq O.T. Therapy of upper gastrointestinal tract cancers. Curr Probl Cancer. 15:1991;235-294.
4. Lauren P. The two histological main types of gastric carcinoma. diffuse and so-called intestinal-type carcinoma Acta Pathol Microbiol Scand. 64:1965;31-49.
5. Lauren P.A., Navalainen J.T. Epidemiology of intestinal and diffuse types of gastric carcinoma. a time trend study in Finland with comparison between studies from high- and low risk areas Cancer. 71:1993;2926-2933.
6. Correa P. Human gastric carcinogenesis. multistep and multifocal process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention Cancer Res. 52:1992;6735-6740.
7. Hirohashi S., Sugimura T. Genetic alterations in human gastric cancer. Cancer Cells. 3:1991;49-52.
8. Park J.G., Frucht H., LaRocca R.V., Bliss D.P. Jr., Kurita Y., Chen T.R., Henslee J.G., Trepel J.B., Jensen R.T., Johnson B.E., Bang Y.J., Kim J.P., Gazdar A.F. Characteristics of cell lines established from human gastric carcinoma. Cancer Res. 50:1990;2773-2780.
9. Yashiro M., Chung Y.S., Nishimura S., Inoue T., Sowa M. Establishment of two new scirrhous gastric cancer cell lines. analysis of factors associated with disseminated metastasis Br J Cancer. 72:1995;1200-1210.
10. Negrini M., Castagnoli A., Pawan J.W., Sabbioni S., Araujo D., Corallini A., Gualandi F., Rimessi P., Bonfanti A., Giunta A., Sensi A., Stanbridge E.J., Barbanti-Brodano G. Suppression of tumorigenicity and anchorage-independent growth of BK virus-transformed mouse cells by human chromosome 11. Cancer Res. 52:1992;1297-1303.
11. Dutrillaux B., Lejeune J. New techniques in the study of human chromosomes. methods and applications Adv Hum Genet. 5:1975;119-156.
12. Zoli W., Roncuzzi L., Zini N., Lenzi L., Gruppioni R., Barzanti F., Sensi A., Amadori D., Gasperi-Campani A. Establishment and characterization of two new cell lines derived from human metastatic breast carcinomas. Breast Cancer Res Treat. 43:1997;141-151.
13. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Smith J.A., Seidman J.G., Struhl K. Current Protocols in Molecular Biology. 1989;Wiley, New York.
14. Southern E.M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 98:1975;503-517.
15. Dalla Favera R., Martinotti S., Gallo R.C., Erikson J., Croce C.M. Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science. 219:1983;963-967.
16. King C.R., Kraus M.H., Aaronson S.A. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science. 229:1985;974-976.
17. Casey G, Smith R, Mc Gillivray D, Peter G, Dickson C (1986): Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene. Mol Cell Biol: 502-510.
18. Watson R., Oskarsson M., Vande Woude G.F. Human DNA sequence homologous to the transforming gene (mos) of Moloney sarcoma virus. Proc Natl Acad Sci USA. 79:1982;4078-4082.
19. Ranzani G.N., Pellegata N.S., Previderè C., Saragoni A., Vio A., Maltoni M., Amadori D. Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients. Cancer Res. 50:1990;7811-7814.
20. Taira M., Yoshida T., Miyagawa K., Sakamoto H., Terada M., Sugimura T. cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. Proc Natl Acad Sci USA. 84:1987;2980-2984.
21. Pulciani S., Santos E., Lauver A.V., Long L.K., Barbacid M. Transforming genes in human tumors. J Cell Biochem. 20:1982;51-61.
22. Cooper C.S., Park M., Blair D.G., Tainsky M.A., Huebner K., Croce C.M., Vande Woude G.F. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature. 311:1984;29-33.
23. Koff A., Cross F., Fisher A., Schumacher J., Lagnellac K., Philippe M., Roberts J.M. Human cyclin E, a new cyclin that interacts with two members of the cdc2 gene family. Cell. 66:1991;1217-1228.
24. Orita M., Suzuki J., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 5:1989;874-879.
25. Tanigawa N., Kern D.H., Hikasa Y., Norton D.L. Rapid assay for evaluating the chemosensitivity of human tumors in soft-agar culture. Cancer Res. 42:1982;2159-2164.
26. Zoli W., Roncuzzi L., Flamigni A., Gruppioni R., Sensi A., Zini N., Amadori D., Gasperi-Campani A. A new cell line from human infiltrating ductal carcinoma of the breast. establishment and characterization J Cancer Res Clin Oncol. 122:1996;237-242.
27. Allum W.H., Hallissey M.T., Kelly K.A. Adjuvant chemotherapy in operable gastric cancer. 5-years follow-up of first British stomach cancer group trial Lancet. 1:1989;571-574.
28. Nabeya Y., Loganzo F. Jr., Maslak P., Lai L., De Oliveira A.R., Schwartz G.K., Blundell M.L., Altorki N.K., Kelsen D.P., Albino A.P. The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents. Int J Cancer. 64:1995;37-46.
29. Posner M.R., Mayer R.J. The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin N Am. 8:1994;533-553.